Could PayPal's Data Ads Push and Index Shift Reframe Its Core Investment Story for PYPL?
Simply Wall St
Kyndryl (KD) Deepens Microsoft Cloud Ties Is Its Regulatory Edge Becoming a Lasting Moat?
Simply Wall St
Expanding RINVOQ And SKYRIZI Uses Might Change The Case For Investing In AbbVie (ABBV)
Simply Wall St
How New Valve Trial Data and Index Reclassification Will Impact Edwards Lifesciences (EW) Investors
Simply Wall St
Nucor (NUE) Stock May Be 46% Undervalued On Cash Flow
Simply Wall St
Marathon Petroleum (MPC) Joins Russell Growth Indexes As Investors Ask If Shares Are Fully Valued
Simply Wall St
How GE's Governance Tweaks and Dividend Move Shape the Engine Backlog Story for GE (GE) Investors
Simply Wall St
This AI Chip Stock Just Signed Massive Deals With 3 Hyperscalers, and It Still Looks Like a Great Buy Right Now (Hint: Not Nvidia or Intel)
Fool.com Headlines
Paylocity Holding (PCTY) Rebounds On Valuation Debate, Is It Undervalued Or Fairly Priced?
Simply Wall St
How UPS's Defensive Index Move And Healthcare Expansion (UPS) Has Changed Its Investment Story
Simply Wall St
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Given Consensus Rating of "Moderate Buy" by Brokerages
The Cerbat Gem
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Given Consensus Recommendation of "Moderate Buy" by Brokerages
The Cerbat Gem
